Tending towards inhibition in response to the insulin treatment, and activation in response to the HF treatment, such a Ca2+-related mechanism might be critical in the onset of impaired granulosa cell function resulting from metabolic challenges especially in type 2 diabetes (T2D) patients. The gene discussed is INS; the disease is type 2 diabetes mellitus.